$KOSS
KOSS CORP Stock $koss

$koss Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-K Financial Statement

#000005670117000038 Filed on August 25, 2017

Income Statement

Concept	2016 Q2	2016	2015 Q2
Revenue	$7.240M	$26.00M	$5.720M
YoY Change	26.57%	7.31%	-7.59%
Cost Of Revenue	$4.720M	$17.06M	$3.640M
YoY Change	29.67%	8.09%	-33.82%
Gross Profit	$2.520M	$8.943M	$2.080M
YoY Change	21.15%	5.85%	197.14%
Gross Profit Margin	34.81%	34.39%	36.36%
Selling, General & Admin	$2.100M	$7.959M	$1.900M
YoY Change	10.53%	0.69%	-25.2%
% of Gross Profit	83.33%	89.01%	91.35%
Research & Development		$91.26K
YoY Change
% of Gross Profit		1.02%
Depreciation & Amortization	$120.0K	$487.1K	$120.0K
YoY Change	0.0%	-12.95%	-25.0%
% of Gross Profit	4.76%	5.45%	5.77%
Operating Expenses	$2.100M	$8.051M	$1.900M
YoY Change	10.53%	1.45%	-25.2%
Operating Profit	$420.0K	$891.9K	$180.0K
YoY Change	133.33%	73.92%	-109.78%
Interest Expense	$0.00	$6.075K	$0.00
YoY Change		-52.59%
% of Operating Profit	0.0%	0.68%	0.0%
Other Income/Expense, Net			$0.00
YoY Change
Pretax Income	$420.0K	$2.263M	$230.0K
YoY Change	82.61%	352.62%	-106.22%
Income Tax	$190.0K	$874.0K	-$120.0K
% Of Pretax Income	45.24%	38.62%	-52.17%
Net Earnings	$230.0K	$1.389M	$350.0K
YoY Change	-34.29%	187.81%	-116.28%
Net Earnings / Revenue	3.18%	5.34%	6.12%
Basic Earnings Per Share		$0.19
Diluted Earnings Per Share	$31.17K	$0.19	$47.43K
COMMON SHARES
Basic Shares Outstanding	7.383M shares	7.383M shares	7.383M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q2	2016	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$740.0K	$740.0K	$1.000M
YoY Change	-26.0%	-26.0%	-47.37%
Cash & Equivalents	$735.4K	$740.0K	$1.000M
Short-Term Investments
Other Short-Term Assets	$280.0K	$280.0K	$350.0K
YoY Change	-20.0%	-20.0%	-87.18%
Inventory	$8.595M	$8.600M	$7.182M
Prepaid Expenses
Receivables	$3.531M	$3.530M	$2.824M
Other Receivables	$580.0K	$580.0K	$210.0K
Total Short-Term Assets	$13.73M	$13.73M	$11.56M
YoY Change	18.74%	18.77%	-27.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.514M	$1.510M	$1.593M
YoY Change	-4.9%	-5.03%	-13.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.880M	$8.880M	$7.229M
YoY Change	22.84%	-4.21%	9.52%
Total Long-Term Assets	$10.39M	$10.39M	$10.87M
YoY Change	-4.35%	-4.42%	28.73%
TOTAL ASSETS
Total Short-Term Assets	$13.73M	$13.73M	$11.56M
Total Long-Term Assets	$10.39M	$10.39M	$10.87M
Total Assets	$24.12M	$24.12M	$22.43M
YoY Change	7.55%	7.53%	-8.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.967M	$1.970M	$2.172M
YoY Change	-9.46%	-9.22%	-11.87%
Accrued Expenses	$1.602M	$1.600M	$1.575M
YoY Change	1.69%	1.27%	-59.13%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.568M	$3.570M	$3.747M
YoY Change	-4.78%	-4.8%	-42.29%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$178.3K	$2.370M	$219.2K
YoY Change	-18.69%	1.72%	-34.9%
Total Long-Term Liabilities	$2.366M	$2.370M	$2.327M
YoY Change	1.69%	1.72%	-12.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.568M	$3.570M	$3.747M
Total Long-Term Liabilities	$2.366M	$2.370M	$2.327M
Total Liabilities	$5.934M	$5.930M	$6.074M
YoY Change	-2.3%	-2.31%	-33.62%
SHAREHOLDERS EQUITY
Retained Earnings	$13.08M		$11.69M
YoY Change	11.88%		4.31%
Common Stock	$5.108M		$4.664M
YoY Change	9.52%		15.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.19M	$18.19M	$16.35M
YoY Change
Total Liabilities & Shareholders Equity	$24.12M	$24.12M	$22.43M
YoY Change	7.55%	7.53%	-8.05%

Cashflow Statement

Concept	2016 Q2	2016	2015 Q2
OPERATING ACTIVITIES
Net Income	$230.0K	$1.389M	$350.0K
YoY Change	-34.29%	187.81%	-116.28%
Depreciation, Depletion And Amortization	$120.0K	$487.1K	$120.0K
YoY Change	0.0%	-12.95%	-25.0%
Cash From Operating Activities	-$30.00K	$310.0K	$20.00K
YoY Change	-250.0%	-191.18%	-105.71%
INVESTING ACTIVITIES
Capital Expenditures	-$160.0K	$449.8K	-$70.00K
YoY Change	128.57%	37.72%	16.67%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$130.0K	$0.00
YoY Change		-43.48%
Cash From Investing Activities	-$160.0K	-$580.0K	-$60.00K
YoY Change	166.67%	3.57%	0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-30.00K	310.0K	20.00K
Cash From Investing Activities	-160.0K	-580.0K	-60.00K
Cash From Financing Activities			0.000
Net Change In Cash	-190.0K	-270.0K	-40.00K
YoY Change	375.0%	-70.0%	-95.29%
FREE CASH FLOW
Cash From Operating Activities	-$30.00K	$310.0K	$20.00K
Capital Expenditures	-$160.0K	$449.8K	-$70.00K
Free Cash Flow	$130.0K	-$139.8K	$90.00K
YoY Change	44.44%	-79.03%	-131.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0000056701
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7382706	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2016Q4	dei	Entity Public Float EntityPublicFloat	5950766	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	KOSS CORP
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016Q2	koss	Accrued Returns AccruedReturns	140918	USD
CY2017Q2	koss	Accrued Returns AccruedReturns	53915	USD
CY2016Q2	koss	Assets Noncurrent Excluding Equipment And Leasehold Improvements AssetsNoncurrentExcludingEquipmentAndLeaseholdImprovements	8879661	USD
CY2017Q2	koss	Assets Noncurrent Excluding Equipment And Leasehold Improvements AssetsNoncurrentExcludingEquipmentAndLeaseholdImprovements	9067186	USD
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016Q2	koss	Cooperative Advertising And Promotion Allowances CooperativeAdvertisingAndPromotionAllowances	479645	USD
CY2017Q2	koss	Cooperative Advertising And Promotion Allowances CooperativeAdvertisingAndPromotionAllowances	415050	USD
CY2016Q2	koss	Customer Refund Liabilities Current CustomerRefundLiabilitiesCurrent	47753	USD
CY2017Q2	koss	Customer Refund Liabilities Current CustomerRefundLiabilitiesCurrent	21175	USD
CY2016	koss	Deferred Compensation Arrangement Distributions Paid DeferredCompensationArrangementDistributionsPaid	150000	USD
CY2017	koss	Deferred Compensation Arrangement Distributions Paid DeferredCompensationArrangementDistributionsPaid	150000	USD
CY2016Q2	koss	Defined Contribution Plan Company Match DefinedContributionPlanCompanyMatch	0.5	Rate
CY2017Q2	koss	Defined Contribution Plan Company Match DefinedContributionPlanCompanyMatch	0.75	Rate
CY2016Q2	koss	Foreignaccountsreceivabledenominatedin U Sdollars ForeignaccountsreceivabledenominatedinUSdollars	0.28	Rate
CY2017Q2	koss	Foreignaccountsreceivabledenominatedin U Sdollars ForeignaccountsreceivabledenominatedinUSdollars	0.15	Rate
CY2016	koss	Gain Contingency Legal Fees GainContingencyLegalFees	1714074	USD
CY2017	koss	Gain Contingency Legal Fees GainContingencyLegalFees	77500	USD
CY2016	koss	Gain Contingency Proceeds From Asset Forfeitures GainContingencyProceedsFromAssetForfeitures	75	USD
CY2017	koss	Gain Contingency Proceeds From Asset Forfeitures GainContingencyProceedsFromAssetForfeitures	9952	USD
CY2016	koss	Gaincontingencygrossproceedsfromlegalsettlements Gaincontingencygrossproceedsfromlegalsettlements	3000000	USD
CY2017	koss	Gaincontingencygrossproceedsfromlegalsettlements Gaincontingencygrossproceedsfromlegalsettlements	0	USD
CY2017	koss	Operating Leases Annual Lease Commitment OperatingLeasesAnnualLeaseCommitment	380000	USD
CY2017	koss	Operating Leases Term OperatingLeasesTerm	P5Y
CY2016Q2	koss	Percent Of Gross Accounts Receivable With Two Largest Customers PercentOfGrossAccountsReceivableWithTwoLargestCustomers	0.18	Rate
CY2017Q2	koss	Percent Of Gross Accounts Receivable With Two Largest Customers PercentOfGrossAccountsReceivableWithTwoLargestCustomers	0.31	Rate
CY2016	koss	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageForfeitureRate	0.0560	Rate
CY2017	koss	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageForfeitureRate	0.1531	Rate
CY2016	koss	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue	0	USD
CY2017	koss	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue	0	USD
CY2016	koss	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateFairValue	583727	USD
CY2017	koss	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateFairValue	461720	USD
CY2016Q2	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Exercisable Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisableExercisePriceLowerLimit	2.24
CY2017Q2	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Exercisable Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisableExercisePriceLowerLimit	2.05
CY2016Q2	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Exercisable Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisableExercisePriceUpperLimit	9.74
CY2017Q2	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Exercisable Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisableExercisePriceUpperLimit	7.76
CY2016	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePriceLowerLimit	0.00
CY2017	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePriceLowerLimit	0.00
CY2016	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePriceUpperLimit	0.00
CY2017	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePriceUpperLimit	0.00
CY2016	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodExercisePriceLowerLimit	3.00
CY2017	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodExercisePriceLowerLimit	2.57
CY2016	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodExercisePriceUpperLimit	13.09
CY2017	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodExercisePriceUpperLimit	9.74
CY2016	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodExercisePriceLowerLimit	3.00
CY2017	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodExercisePriceLowerLimit	2.20
CY2016	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodExercisePriceUpperLimit	6.00
CY2017	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodExercisePriceUpperLimit	5.30
CY2016	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePriceLowerLimit	2.05
CY2017	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePriceLowerLimit	2.20
CY2016	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePriceUpperLimit	2.83
CY2017	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePriceUpperLimit	2.42
CY2015Q2	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit	2.24
CY2016Q2	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit	2.05
CY2017Q2	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Exercise Price Lower Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit	2.05
CY2015Q2	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit	13.09
CY2016Q2	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit	9.74
CY2017Q2	koss	Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Exercise Price Upper Limit ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit	7.76
CY2017Q2	koss	Stock Repurchase Program Inception To Date Repurchased StockRepurchaseProgramInceptionToDateRepurchased	43360247	USD
CY2017	koss	Stock Repurchase Program Maximum Amount Board Will Approve Per Repurchase StockRepurchaseProgramMaximumAmountBoardWillApprovePerRepurchase	2000000	USD
CY2016	koss	Unauthorized Transaction Related Costs Recoveries Net UnauthorizedTransactionRelatedCostsRecoveriesNet	-1286001	USD
CY2017	koss	Unauthorized Transaction Related Costs Recoveries Net UnauthorizedTransactionRelatedCostsRecoveriesNet	67548	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1966656	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2243110	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3530854	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3931541	USD
CY2016Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	132950	USD
CY2017Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	0	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1601652	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1149395	USD
CY2016Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	127329	USD
CY2017Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	86500	USD
CY2016Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	84550	USD
CY2017Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	83654	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7371324	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7709399	USD
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5070956	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5420710	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	444175	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	349754	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	143518	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	147797	USD
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	26052	USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	55175	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	55872	USD
CY2016	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	29123	USD
CY2017	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	697	USD
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2140000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2180000	shares
CY2016Q2	us-gaap	Assets Assets	24120471	USD
CY2017Q2	us-gaap	Assets Assets	23423653	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	13726338	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	12948376	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1000266	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	735393	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	432283	USD
CY2016Q2	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	5667105	USD
CY2017Q2	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	6024929	USD
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7382706	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7382706	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7382706	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7382706	shares
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	36914	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	36914	USD
CY2016	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17058774	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17158977	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	169350	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	19822	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2675	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	425	USD
CY2016	us-gaap	Deferred Compensation Arrangement With Individual Distribution Paid DeferredCompensationArrangementWithIndividualDistributionPaid	150000	USD
CY2017	us-gaap	Deferred Compensation Arrangement With Individual Distribution Paid DeferredCompensationArrangementWithIndividualDistributionPaid	150000	USD
CY2016Q2	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2187714	USD
CY2017Q2	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2294418	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	186877	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	303950	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	487134	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	503585	USD
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2016Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	150000	USD
CY2017Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	150000	USD
CY2016	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	702013	USD
CY2017	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	170299	USD
CY2016Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3212556	USD
CY2017Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3042257	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	702013	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	170299	USD
CY2016Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3282889	USD
CY2017Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3113194	USD
CY2016Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	418296	USD
CY2017Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	751021	USD
CY2016Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5979	USD
CY2017Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	864954	USD
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	904435	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	603159	USD
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	621966	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1390910	USD
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1280181	USD
CY2016Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	409	USD
CY2017Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	444409	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2943	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3262	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	67390	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	67675	USD
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	83113	USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	54074	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	790637	USD
CY2017	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M11D
CY2016	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	0	USD
CY2017	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	0	USD
CY2017Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	1	Rate
CY2016	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-40710	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-6230	USD
CY2016	us-gaap	Gross Profit GrossProfit	8942572	USD
CY2017	us-gaap	Gross Profit GrossProfit	6895304	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2263038	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-773090	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	874038	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	190546	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-370000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	444000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	769433	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-262851	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	447180	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	51197	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-64235	USD
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-9513	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	91660	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-32287	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	558202	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-523342	USD
CY2016Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	583507	USD
CY2017Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	32814	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-205598	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	276454	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	735388	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	398815	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	26625	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-452257	USD
CY2016	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	230228	USD
CY2017	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	256704	USD
CY2016	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	377976	USD
CY2017	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-550693	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1413045	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-250142	USD
CY2016	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2679409	USD
CY2017	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-287084	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-40972	USD
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-13837	USD
CY2016	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-66945	USD
CY2017	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-74704	USD
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2016	us-gaap	Interest Expense InterestExpense	6075	USD
CY2017	us-gaap	Interest Expense InterestExpense	964	USD
CY2016	us-gaap	Interest Expense Debt InterestExpenseDebt	6075	USD
CY2017	us-gaap	Interest Expense Debt InterestExpenseDebt	964	USD
CY2016	us-gaap	Interest Paid InterestPaid	6075	USD
CY2017	us-gaap	Interest Paid InterestPaid	964	USD
CY2016Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7570026	USD
CY2017Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7895561	USD
CY2016Q2	us-gaap	Inventory Gross InventoryGross	11036933	USD
CY2017Q2	us-gaap	Inventory Gross InventoryGross	10796060	USD
CY2016Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	471174	USD
CY2017Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	0	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-579498	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-537362	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	314625	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	234252	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	1389000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	8595485	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	8345343	USD
CY2016Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	3466907	USD
CY2017Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	2900499	USD
CY2016Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2441448	USD
CY2017Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2450717	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	380000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	380000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	5934277	USD
CY2017Q2	us-gaap	Liabilities Liabilities	5851341	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24120471	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23423653	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3568308	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3392505	USD
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2365969	USD
CY2017Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2458836	USD
CY2016	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	177740	USD
CY2017	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	223896	USD
CY2010Q2	us-gaap	Line Of Credit Facility Capacity Available For Trade Purchases LineOfCreditFacilityCapacityAvailableForTradePurchases	2000000	USD
CY2010Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	8000000	USD
CY2017Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	4000000	USD
CY2016Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2017Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2016	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-264873	USD
CY2017	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-303110	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-963636	USD
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	50119	USD
CY2017Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	64486	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	178255	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	164418	USD
CY2016	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	129702	USD
CY2017	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	133928	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	449796	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	403434	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	281099	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	206395	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2016Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	305275	USD
CY2017Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	220541	USD
CY2016	us-gaap	Product Warranty Expense ProductWarrantyExpense	263188	USD
CY2017	us-gaap	Product Warranty Expense ProductWarrantyExpense	258561	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8885796	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9117490	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1514472	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1408091	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	28514	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1872	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	91259	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	213653	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	13078324	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12114688	USD
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	26001346	USD
CY2017	us-gaap	Sales Revenue Net SalesRevenueNet	24054281	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7959460	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7599882	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0400	Rate
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	Rate
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	Rate
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.54	Rate
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0148	Rate
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0117	Rate
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2000000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1334308	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1084000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1105166	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.57
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.88
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	458000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	372000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	57000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	73000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	410000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.75
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	485000	shares
CY2016	us-gaap	Standard Product Warranty Accrual Period Increase Decrease StandardProductWarrantyAccrualPeriodIncreaseDecrease	214827	USD
CY2017	us-gaap	Standard Product Warranty Accrual Period Increase Decrease StandardProductWarrantyAccrualPeriodIncreaseDecrease	159990	USD
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2016	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	444175	USD
CY2017	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	349754	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.07
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1676	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2245000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2140000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2180000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.33
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.66
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.93
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.25
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.24
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.34
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.00
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.72
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.33
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y6M0D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M23D
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y5M20D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y3M11D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M7D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M5D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y5M20D
CY2015Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	531891	USD
CY2016Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	483530	USD
CY2017Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	384959	USD
CY2017Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	45500000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	16353019	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	18186194	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	17572312	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7382706	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7382706	shares
CY2017	us-gaap	Advertising Cost Policy Expensed Advertising Cost AdvertisingCostPolicyExpensedAdvertisingCost	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ADVERTISING COSTS — Advertising costs included within selling, general and administrative expenses in the accompanying Consolidated Statements of Operations were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$147,797</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$143,518</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">.  Such costs are expensed as incurred.</font></div></div>
CY2017	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RECLASSIFICATIONS — Certain amounts previously reported have been reclassified to conform to the current presentation.</font></div></div>
CY2017	us-gaap	Revenue Recognition Sales Of Goods RevenueRecognitionSalesOfGoods	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">REVENUE RECOGNITION — The Company recognizes revenue when all of the following criteria are met: persuasive evidence of an arrangement exists; shipment and delivery have occurred; the seller’s price to the buyer is fixed and determinable; and collectibility is reasonably assured.  When these criteria are generally satisfied, the Company recognizes revenue.  The Company also offers certain customers the right to return products that do not meet the standards agreed on with the customer.  The Company continuously monitors such product returns and cannot guarantee that they will continue to experience the same return rates that they have experienced in the past. The Company records a provision for estimated returns based on prior product rates of return.  Any significant increase in product quality failure rates and the resulting credit returns could have a material adverse impact on the Company’s operating results for the period or periods in which such returns materialize.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides for certain sales incentives.  The Company records a provision for estimated incentives based upon the incentives offered to customers on product related sales in the same period as the related revenues are recorded.  The provision is recorded as a reduction of sales.  The Company also records a provision for estimated sales returns and allowances on product related sales in the same period as the related revenues are recorded.  These estimates are based on historical sales returns, analysis of credit memo data and other known factors.  If the historical data the Company uses to calculate these estimates does not properly reflect future returns, adjustments may be required in future periods.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">USE OF ESTIMATES — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
R41.htm	Edgar Link	pending
0000056701-17-000038-index-headers.html	Edgar Link	pending
R42.htm	Edgar Link	pending
0000056701-17-000038-index.html	Edgar Link	pending
0000056701-17-000038.txt	Edgar Link	pending
0000056701-17-000038-xbrl.zip	Edgar Link	pending
exhibit1015seventhamendmen.htm	Edgar Link	pending
exhibit231consentofindepen.htm	Edgar Link	pending
exhibit31106302017.htm	Edgar Link	pending
exhibit31206302017.htm	Edgar Link	pending
exhibit32106302017.htm	Edgar Link	pending
exhibit32206302017.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
fy201710-k.htm	Edgar Link	pending
koss-20170630.xml	Edgar Link	completed
koss-20170630.xsd	Edgar Link	pending
koss-20170630_cal.xml	Edgar Link	unprocessable
koss-20170630_def.xml	Edgar Link	unprocessable
koss-20170630_lab.xml	Edgar Link	unprocessable
koss-20170630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KOSS
KOSS CORP Stock $koss

2016 Q2 Form 10-K Financial Statement

#000005670117000038 Filed on August 25, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOSS KOSS CORP Stock $koss

2016 Q2 Form 10-K Financial Statement

#000005670117000038 Filed on August 25, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOSS
KOSS CORP Stock $koss